Evidence map›Paper›PMID 32890522›Full record

ArticleInternational journal of radiation oncology, biology, physics2020

Telemedicine for Radiation Oncology in a Post-COVID World.

Sean Maroongroge, Benjamin Smith, Elizabeth S Bloom, Matthew S Ning, Chenyang Wang, Prajnan Das, Albert C Koong, Mary Frances McAleer, Kristina D Woodhouse

Abstract readEditorial
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sean MaroongrogeDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: SMaroongroge@mdanderson.org.
Benjamin SmithDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Elizabeth S BloomDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Matthew S NingDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Chenyang WangDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Prajnan DasDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Albert C KoongDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Mary Frances McAleerDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Kristina D WoodhouseDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Attitude of Health PersonnelCancer Care FacilitiesCOVID-19HumansPhysical ExaminationRadiation OncologyRisk AssessmentTelemedicine

Identifiers

PMID32890522
PMCPMC7462809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.